| Title： | Leadless Pacemaker:Operation Procedure and Standard |
| Edition： | Original |
| Classification： | Standard guideline |
| Field： | Diagnosis and Treatment |
| Countries and regions： | China |
| Guidelines users： | Physicians |
| Evidence classification method： | Recommendated: Good scientific evidence suggests that the benefits of the medical practice substantially outweigh the potential risks. Clinicians should discuss the medical practice with indicated patient reports; *Should be considered: At least fair evidence that the benefits of the medical practice outweigh the potential risks. Clinicians should discuss the medical practice with indicated patients; * May be considered: At least fair scientific evidence suggests that the medical practice provides benefits, but the benefits are too close to the risks to make a general recommendation. Clinicians are not required to provide this medical practice unless certain individual considerations exist; * Not recommended: At least fair scientific evidence suggests that the potential risks of this medical practice outweigh the potential benefits; clinicians should not routinely perform this medical practice on asymptomatic patients; |
| Development unit： | Chinese Society of Arrthymia, China Society of Pacing and Electrophysiology |
| Registration time: | 2022-06-18 |
| Registration number： | IPGRP-2022CN350 |
| Purpose of the guideline: | "The pacemaker is the only effective treatment for bradyarrhythmias, and the leadless pacemaker is a milestone change and progress in the history of cardiac pacing therapy. It has accumulated a lot of experience in various aspects in the process of clinical promotion and popularization. The CSA and CSPE jointly advocated and organized the writing of this expert consensus, aiming to standardize the clinical application of this new technology and make this technology safer and can carry out orderly in China Pacemakers are the mainstream treatment for patients with bradycardia. Conventional transvensous pacemaker may lead to complications due to the leads and pockets. The leadless pacemaker is directly implanted into the heart via veins. Without lead and subcutaneous pockets, it will greatly reduce the incidence of complications. Because the implantation procedure and patient management of leadless pacemakers are quite different from those of traditional pacemakers, The CSA and CSPE jointly organized and wrote the standard operating procedures and starndard aiming to standardize the clinical application of this new technology." |
Latest registration
